Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to…
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first…
Health insurance premiums are primarily understood to pose financial barriers to coverage. However, the need to remit monthly premium…
Are application hassles, or “ordeals,” an effective way to limit public program enrollment? We provide new evidence by studying (removal of…
There are widespread differences in total factor productivity across producers in the U.S. and around the world. To help explain these…
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population…
Incomplete health insurance enrollment is a persistent U.S. challenge despite large subsidies. We ask whether hassles built into enrollment…
How do media portrayals of potential policy beneficiaries’ identities sway public support for these policies in a public health setting?…
Health plans for the poor increasingly limit access to specialty hospitals. We investigate the role of adverse selection in generating this…
One of our great urbanists and one of our great public health experts join forces to reckon with how cities are changing in the face of…